Literature DB >> 12566933

Serum leptin and cholesterol levels in patients with bipolar disorder.

Murad Atmaca1, Murat Kuloglu, Ertan Tezcan, Bilal Ustundag, Yilmaz Bayik.   

Abstract

Low cholesterol levels have been reported in patients with manic episodes. Leptin seems to be strongly associated with lipid metabolism. In the present study, therefore, serum total cholesterol and leptin levels were compared in 16 patients with manic episodes, 16 with bipolar I disorder in full remission and 16 healthy controls. The serum total cholesterol and leptin levels were measured and Young Mania Rating (YMRS) and Hamilton Depression Rating Scales (HAM-D) were administered for each subject. Both the patients with manic episodes and the patients with bipolar I disorder in full remission had markedly low serum cholesterol and leptin levels compared with controls, though the difference was more obvious in patients with manic episodes. In addition, there were negative correlations between YMRS scores and serum cholesterol or leptin levels in the patients with manic episodes. Our results suggest that the patients with manic episodes and those with bipolar I disorder in full remission seem to be associated with decreased serum cholesterol and leptin levels. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12566933     DOI: 10.1159/000067809

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  22 in total

1.  Fasting leptin and glucose in normal weight, over weight and obese men and women diabetes patients with and without clinical depression.

Authors:  Darakhshan Jabeen Haleem; Shehnaz Sheikh; Asher Fawad; Muhammad A Haleem
Journal:  Metab Brain Dis       Date:  2017-02-15       Impact factor: 3.584

2.  Nasal administration of leptin dose-dependently increases dopamine and serotonin outflow in the rat nucleus accumbens.

Authors:  Sonya Neto; Ramya Varatharajan; Kevin Joseph; Andreas Moser
Journal:  J Neural Transm (Vienna)       Date:  2016-07-13       Impact factor: 3.575

Review 3.  The impact of leptin on perinatal development and psychopathology.

Authors:  Jeanette C Valleau; Elinor L Sullivan
Journal:  J Chem Neuroanat       Date:  2014-05-23       Impact factor: 3.052

4.  Alterations of Lipid-Lipoprotein and Leptin in Bipolar Disorder Associated with Clinic Process.

Authors:  Feridun Bülbül; Ayşegül Giray Eryiğit; A Binnur Erbağci; Salih Selek; Haluk Savaş
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

5.  Cholesterol and affective morbidity.

Authors:  Jess G Fiedorowicz; Narasimha M Palagummi; Ole Behrendtsen; William H Coryell
Journal:  Psychiatry Res       Date:  2009-12-06       Impact factor: 3.222

6.  Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Psychiatr Res       Date:  2013-07-18       Impact factor: 4.791

Review 7.  The leptin hypothesis of depression: a potential link between mood disorders and obesity?

Authors:  Xin-Yun Lu
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

8.  Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine.

Authors:  Jing Liu; Jacob C Garza; Jamaur Bronner; Chung Sub Kim; Wei Zhang; Xin-Yun Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

9.  Medical burden in late-life bipolar and major depressive disorders.

Authors:  Ariel G Gildengers; Ellen M Whyte; Rebecca A Drayer; Isabella Soreca; Andrea Fagiolini; Amy M Kilbourne; Patricia R Houck; Charles F Reynolds; Ellen Frank; David J Kupfer; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2008-03       Impact factor: 4.105

10.  Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment.

Authors:  Byungsu Kim; Sangeok Kim; Roger S McIntyre; Hui Joon Park; Seong Yoon Kim; Yeon Ho Joo
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.